North America Blood Collection Devices Market Size, Share & Industry Trends Analysis Report By End User, By Product, By Tubes Type, By Plasma/whole-blood Tubes Type, By Tubes System Type, By Method, By Application, By Country and Growth Forecast, 2021-2027

The North America Blood Collection Devices Market is expected to witness market growth of 5.5% CAGR during the forecast period (2021-2027).

Blood collection devices are utilized for the treatment of patients going through dialysis, chemotherapy, tissue & organ transplantation, and various surgeries. The rising prevalence instances of lifestyle diseases and chronic diseases because of inactive lifestyles have made it essential to go through regular health checkups. This has further increased the need for blood collection as the primary mode of diagnosing diseases. Other than this, governments and other ruling authorities of a few nations are taking drives to increase blood donations and spread awareness about the importance of blood donation due to the outbreak of COVID-19.

These programs have supported the growth of the blood collection market worldwide over the pandemic period. Additionally, advancements in technologies in the field of blood collection are also driving the growth. For example, market players have launched a push-button blood collection device that is utilized for testing HbA1c levels in diabetic as well as prediabetic patients. Some other factors responsible for the growth are the rising number of accidents along with the adoption of preventive care and diagnostics among people.

The increasing number of road accidents and the rise in the spread of chronic diseases in North America are the major factors responsible for the regional market growth. As per the data published by the World Health Organization in 2018, road accidents deaths in the Mexico region was around 15,292 or 2.70%. This high number of accidents in this region is resulting in high demand for blood collection devices. 

Moreover, the American National Red Cross, 2021, updates that there is a need for approximately 36000 units of RBC every day and around 21 million blood components are transfused in the United States every year. Also, the Diabetes Research Institute Foundation mentioned that approximately 1.5 million new cases of diabetes were diagnosed among people aged 18 or older in the United States in 2018. This rising number of chronic diseases along with lifestyle-related disorders arise the need for blood collection.

The US market dominated the North America Blood Collection Devices Market by Country 2020, and is expected to continue to be a dominant market till 2027; thereby, achieving a market value of $2,012.7 million by 2027. The Canada market is anticipated to grow at a CAGR of 8% during (2021 - 2027). Additionally, The Mexico market is expected to witness a CAGR of 7% during (2021 - 2027).

Based on End User, the market is segmented into Hospitals, Ambulatory Surgical Centers, & Nursing Homes; Diagnostic & Pathology Laboratories, Blood Banks and Others. Based on Product, the market is segmented into Blood Collection Tubes, Needles & Syringes, Blood Bags, Blood Collection Systems/Monitors and Lancets. Based on Tubes Type, the market is segmented into Plasma/whole-blood Tubes and Serum Tubes. Based on Plasma/whole-blood Tubes Type, the market is segmented into EDTA Tubes, Heparin Tubes, Coagulation Tubes, Glucose Tubes and Others. Based on Tubes System Type, the market is segmented into Vacuum Tubes and Non-Vacuum Tubes. Based on Method, the market is segmented into Manual Blood Collection and Automatic Blood Collection. Based on Application, the market is segmented into Diagnostics and Therapeutics. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Sarstedt AG & Company, ICU Medical, Inc., Grifols, S.A., Retractable Technologies, Inc., Quest Diagnostics Incorporated, Becton, Dickinson and Company, Haemonetics Corporation, Terumo Corporation, Fresenius SE & Co. KGaA, and Cardinal Health, Inc.

Scope of the Study

Market Segments Covered in the Report:

By End User

• Hospitals, Ambulatory Surgical Centers, & Nursing Homes
• Diagnostic & Pathology Laboratories
• Blood Banks
• Others

By Product

• Blood Collection Tubes
• Needles & Syringes
• Blood Bags
• Blood Collection Systems/Monitors
• Lancets

By Tubes Type

• Plasma/whole-blood Tubes
• Serum Tubes

By Plasma/whole-blood Tubes Type

• EDTA Tubes
• Heparin Tubes
• Coagulation Tubes
• Glucose Tubes
• Others

By Tubes System Type

• Vacuum Tubes
• Non-Vacuum Tubes

By Method

• Manual Blood Collection
• Automatic Blood Collection

By Application

• Diagnostics
• Therapeutics

By Country: US, Canada, Mexico, and Rest of North America.

Key Market Players

List of Companies Profiled in the Report:

• Sarstedt AG & Company
• ICU Medical, Inc.
• Grifols, S.A.
• Retractable Technologies, Inc.
• Quest Diagnostics Incorporated
• Becton, Dickinson and Company
• Haemonetics Corporation
• Terumo Corporation
• Fresenius SE & Co. KGaA
• Cardinal Health, Inc.

Unique Offerings from the Publisher

• Exhaustive coverage
• The highest number of market tables and figures
• Subscription-based model available
• Guaranteed best price
• Assured post sales research support with 10% customization free